Mucosal macrophages and the regulation of immune responses in the intestine

Immunology Letters

Volumn 119, Issue 1-2, 2008, Pages 22-31

  Platt, Andrew M ^a   Mowat, Allan McI ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Immunoregulation; Intestine; Macrophage; Toll like receptor

Indexed keywords

CYTOKINE; MONOCLONAL ANTIBODY; PROTEIN;

ANTIGEN PRESENTATION; BACTERIUM; CELL STIMULATION; COMMENSAL; ENTERITIS; IMMUNE RESPONSE; IMMUNITY; IMMUNOCHEMISTRY; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; INTESTINE MUCOSA; MACROPHAGE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; T LYMPHOCYTE;

ANIMALS; FEEDBACK, BIOCHEMICAL; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION MEDIATORS; INTESTINES; MACROPHAGE ACTIVATION; MACROPHAGES; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 47149110368     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.05.009     Document Type: Review

References (137)

1. Lee S.H., Starkey P.M., and Gordon S. Quantitative analysis of total macrophage content in adult mouse tissues Immunochemical studies with monoclonal antibody F4/80. J Exp Med 161 (1985) 475-489
2. Macpherson A.J., and Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4 (2004) 478-485
3. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66 (1998) 5224-5231
4. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
5. Sutherland L., Singleton J., Sessions J., Hanauer S., Krawitt E., Rankin G., et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32 (1991) 1071-1075
6. Turunen U.M., Farkkila M.A., Hakala K., Seppala K., Sivonen A., Ogren M., et al. Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 115 (1998) 1072-1078
7. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278 (2003) 5509-5512
8. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
9. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
10. Smith P., Mangan N.E., Walsh C.M., Fallon R.E., McKenzie A.N., van Rooijen N., et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178 (2007) 4557-4566
11. Hirotani T., Lee P.Y., Kuwata H., Yamamoto M., Matsumoto M., Kawase I., et al. The nuclear IκB protein IκBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 174 (2005) 3650-3657
12. Rogler G., Hausmann M., Vogl D., Aschenbrenner E., Andus T., Falk W., et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 112 (1998) 205-215
13. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., Benjamin W.H., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115 (2005) 66-75
14. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
15. Chieppa M., Rescigno M., Huang A.Y., and Germain R.N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med 203 (2006) 2841-2852
16. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3 (2003) 331-341
17. Hornef M.W., Normark B.H., Vandewalle A., and Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198 (2003) 1225-1235
18. Hornef M.W., Frisan T., Vandewalle A., Normark S., and Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 195 (2002) 559-570
19. Eckmann L., Kagnoff M.F., and Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61 (1993) 4569-4574
20. Reinecker H.C., Loh E.Y., Ringler D.J., Mehta A., Rombeau J.L., and MacDermott R.P. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108 (1995) 40-50
21. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
22. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167 (2001) 2651-2656
23. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., and Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 266 (1991) 19490-19498
24. Hooper L.V., Midtvedt T., and Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002) 283-307
25. Weintraub A., Zahringer U., Wollenweber H.W., Seydel U., and Rietschel E.T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 183 (1989) 425-431
26. Kamada N., Hisamatsu T., Okamoto S., Sato T., Matsuoka K., Arai K., et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175 (2005) 6900-6908
27. Mahida Y.R., Wu K.C., and Jewell D.P. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 30 (1989) 1362-1370
28. Ikeda I., Kasajima T., Ishiyama S., Shimojo T., Takeo Y., Nishikawa T., et al. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 92 (1997) 1339-1341
29. Roberts P.J., Riley G.P., Morgan K., Miller R., Hunter J.O., and Middleton S.J. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol 54 (2001) 293-297
30. Hausmann M., Kiessling S., Mestermann S., Webb G., Spottl T., Andus T., et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122 (2002) 1987-2000
31. Kielian T.L., and Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 29 (1995) 187-205
32. + population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin Exp Immunol 100 (1995) 291-297
33. Nakata K., Inagawa H., Nishizawa T., Kohchi C., and Soma G.I. Specific messenger RNA expression for signal transduction molecules by lipopolysaccharide in intestinal macrophages. Clin Exp Immunol 143 (2006) 484-493
34. Monteleone I., Platt A.M., Jaensson E., Agace W.W., and Mowat A.M. IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function. Eur J Immunol (2008)
35. Gorter A., Hiemstra P.S., Leijh P.C., van der Sluys M.E., van den Barselaar M.T., van Es L.A., et al. IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. Immunology 61 (1987) 303-309
36. Schenk M., Bouchon A., Birrer S., Colonna M., and Mueller C. Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol 174 (2005) 517-524
37. Bouchon A., Dietrich J., and Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164 (2000) 4991-4995
38. Schenk M., Bouchon A., Seibold F., and Mueller C. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 117 (2007) 3097-3106
39. Chung E.Y., Liu J., Homma Y., Zhang Y., Brendolan A., Saggese M., et al. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27 (2007) 952-964
40. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164 (2000) 3476-3479
41. Medvedev A.E., Lentschat A., Wahl L.M., Golenbock D.T., and Vogel S.N. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 169 (2002) 5209-5216
42. Adib-Conquy M., and Cavaillon J.M. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem 277 (2002) 27927-27934
43. Hedl M., Li J., Cho J.H., and Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci USA 104 (2007) 19440-19445
44. Wang J.H., Doyle M., Manning B.J., Di Wu Q., Blankson S., and Redmond H.P. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J Biol Chem 277 (2002) 36068-36075
45. Randow F., and Seed B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat Cell Biol 3 (2001) 891-896
46. Yang Y., Liu B., Dai J., Srivastava P.K., Zammit D.J., Lefrancois L., et al. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26 (2007) 215-226
47. Schreiter K., Hausmann M., Spoettl T., Strauch U.G., Bataille F., Schoelmerich J., et al. Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease. Gut 54 (2005) 935-943
48. Chuang T.H., and Ulevitch R.J. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol 5 (2004) 495-502
49. Contractor N., Louten J., Kim L., Biron C.A., and Kelsall B.L. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFβ, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol 179 (2007) 2690-2694
50. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., and Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004) 527-538
51. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., et al. Epithelial-cell-intrinsic IKKβ expression regulates intestinal immune homeostasis. Nature 446 (2007) 552-556
52. Tsunawaki S., Sporn M., Ding A., and Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 334 (1988) 260-262
53. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 174 (1991) 1549-1555
54. Autschbach F., Schurmann G., Braunstein J., Niemir Z., Wallich R., Otto H.F., et al. In situ expression of interleukin-10 messenger RNA in Crohn disease and ulcerative colitis. Verh Dtsch Ges Pathol 80 (1996) 218
55. Avery A., Paraskeva C., Hall P., Flanders K.C., Sporn M., and Moorghen M. TGFβ expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 68 (1993) 137-139
56. Arranz A., Androulidaki A., Zacharioudaki V., Martinez C., Margioris A.N., Gomariz R.P., et al. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol Immunol 45 (2008) 2970-2980
57. Delgado M., Gonzalez-Rey E., and Ganea D. Vasoactive intestinal peptide: the dendritic cell → regulatory T cell axis. Ann N Y Acad Sci 1070 (2006) 233-238
58. Spottl T., Hausmann M., Kreutz M., Peuker A., Vogl D., Scholmerich J., et al. Monocyte differentiation in intestine-like macrophage phenotype induced by epithelial cells. J Leukoc Biol 70 (2001) 241-251
59. Asseman C., Mauze S., Leach M.W., Coffman R.L., and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190 (1999) 995-1004
60. Randow F., Syrbe U., Meisel C., Krausch D., Zuckermann H., Platzer C., et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J Exp Med 181 (1995) 1887-1892
61. Moreno C., Merino J., Vazquez B., Ramirez N., Echeverria A., Pastor F., et al. Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression. Scand J Immunol 59 (2004) 553-558
62. Schottelius A.J., Mayo M.W., Sartor R.B., and Baldwin Jr. A.S. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J Biol Chem 274 (1999) 31868-31874
63. Kuwata H., Watanabe Y., Miyoshi H., Yamamoto M., Kaisho T., Takeda K., et al. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNFα production in macrophages. Blood 102 (2003) 4123-4129
64. Naiki Y., Michelsen K.S., Zhang W., Chen S., Doherty T.M., and Arditi M. Transforming growth factor-β differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 280 (2005) 5491-5495
65. Zeng H., Ornatowska M., Joo M.S., and Sadikot R.T. TREM-1 expression in macrophages is regulated at transcriptional level by NFκB and PU 1. Eur J Immunol 37 (2007) 2300-2308
66. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (2000) 1768-1771
67. Broderick C., Hoek R.M., Forrester J.V., Liversidge J., Sedgwick J.D., and Dick A.D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 161 (2002) 1669-1677
68. Jenmalm M.C., Cherwinski H., Bowman E.P., Phillips J.H., and Sedgwick J.D. Regulation of myeloid cell function through the CD200 receptor. J Immunol 176 (2006) 191-199
69. Zhang S., Cherwinski H., Sedgwick J.D., and Phillips J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol 173 (2004) 6786-6793
70. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311 (2006) 83-87
71. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 196 (2002) 517-527
72. Geissmann F., Jung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
73. Crofton R.W., Diesselhoff-den Dulk M.M., and van Furth R. The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med 148 (1978) 1-17
74. Matute-Bello G., Lee J.S., Frevert C.W., Liles W.C., Sutlief S., Ballman K., et al. Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice. J Immunol Methods 292 (2004) 25-34
75. Tarling J.D., Lin H.S., and Hsu S. Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J Leukoc Biol 42 (1987) 443-446
76. Grimm M.C., Pullman W.E., Bennett G.M., Sullivan P.J., Pavli P., and Doe W.F. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 10 (1995) 387-395
77. Rugtveit J., Brandtzaeg P., Halstensen T.S., Fausa O., and Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35 (1994) 669-674
78. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
79. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
80. Tebbutt N.C., Giraud A.S., Inglese M., Jenkins B., Waring P., Clay F.J., et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8 (2002) 1089-1097
81. Denning T.L., Wang Y.C., Patel S.R., Williams I.R., and Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8 (2007) 1086-1094
82. Lin H.H., Faunce D.E., Stacey M., Terajewicz A., Nakamura T., Zhang-Hoover J., et al. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 201 (2005) 1615-1625
83. Qualls J.E., Kaplan A.M., van Rooijen N., and Cohen D.A. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 80 (2006) 802-815
84. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
85. Rakoff-Nahoum S., Hao L., and Medzhitov R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25 (2006) 319-329
86. Gibson D.L., Ma C., Rosenberger C.M., Bergstrom K.S., Valdez Y., Huang J.T., et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 10 (2008) 388-403
87. Pull S.L., Doherty J.M., Mills J.C., Gordon J.I., and Stappenbeck T.S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102 (2005) 99-104
88. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., and Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115 (2005) 695-702
89. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8 (2006) 1327-1336
90. Wenneras C., Ave P., Huerre M., Arondel J., Ulevitch R.J., Mathison J.C., et al. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol 164 (2000) 3214-3221
91. Yrlid U., and Wick M.J. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med 191 (2000) 613-624
92. Hausmann M., Bataille F., Spoettl T., Schreiter K., Falk W., Schoelmerich J., et al. Physiological role of macrophage inflammatory protein-3 alpha induction during maturation of intestinal macrophages. J Immunol 175 (2005) 1389-1398
93. Salazar-Gonzalez R.M., Niess J.H., Zammit D.J., Ravindran R., Srinivasan A., Maxwell J.R., et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24 (2006) 623-632
94. Little M.C., Bell L.V., Cliffe L.J., and Else K.J. The characterization of intraepithelial lymphocytes, lamina propria leukocytes, and isolated lymphoid follicles in the large intestine of mice infected with the intestinal nematode parasite Trichuris muris. J Immunol 175 (2005) 6713-6722
95. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3 (2003) 23-35
96. Bonecchi R., Sozzani S., Stine J.T., Luini W., D'Amico G., Allavena P., et al. Divergent effects of interleukin-4 and interferon-γon macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 92 (1998) 2668-2671
97. Andrew D.P., Chang M.S., McNinch J., Wathen S.T., Rihanek M., Tseng J., et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 161 (1998) 5027-5038
98. Kodelja V., Muller C., Tenorio S., Schebesch C., Orfanos C.E., and Goerdt S. Differences in angiogenic potential of classically vs. alternatively activated macrophages. Immunobiology 197 (1997) 478-493
99. Laroux F.S., and Grisham M.B. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation 8 (2001) 283-301
100. Kanai T., Watanabe M., Okazawa A., Sato T., Yamazaki M., Okamoto S., et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 121 (2001) 875-888
101. Banks C., Bateman A., Payne R., Johnson P., and Sheron N. Chemokine expression in IBD Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 199 (2003) 28-35
102. Garside P. Cytokines in experimental colitis. Clin Exp Immunol 118 (1999) 337-339
103. Hausmann M., Spottl T., Andus T., Rothe G., Falk W., Scholmerich J., et al. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages. Clin Exp Immunol 125 (2001) 48-55
104. Rutgeerts P., Van Assche G., and Vermeire S. Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Aliment Pharmacol Ther 23 (2006) 451-463
105. Baert F.J., D'Haens G.R., Peeters M., Hiele M.I., Schaible T.F., Shealy D., et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116 (1999) 22-28
106. Popivanova B.K., Kitamura K., Wu Y., Kondo T., Kagaya T., Kaneko S., et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118 (2008) 560-570
107. hi T cells. J Exp Med 190 (1999) 1479-1492
108. Mundy R., MacDonald T.T., Dougan G., Frankel G., and Wiles S. Citrobacter rodentium of mice and man. Cell Microbiol 7 (2005) 1697-1706
109. Watanabe N., Ikuta K., Okazaki K., Nakase H., Tabata Y., Matsuura M., et al. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis Sci 48 (2003) 408-414
110. +-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res 45 (1996) 181-191
111. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652
112. Chen Y., Lui V.C., Rooijen N.V., and Tam P.K. Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut. Gut 53 (2004) 1772-1780
113. Menzel K., Hausmann M., Obermeier F., Schreiter K., Dunger N., Bataille F., et al. Cathepsins B L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol 146 (2006) 169-180
114. Keshavarzian A., Banan A., Farhadi A., Komanduri S., Mutlu E., Zhang Y., et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52 (2003) 720-728
115. Theiss A.L., Simmons J.G., Jobin C., and Lund P.K. Tumor necrosis factor (TNF) α increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem 280 (2005) 36099-36109
116. Demetter P., De Vos M., Van Huysse J.A., Baeten D., Ferdinande L., Peeters H., et al. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163. Ann Rheum Dis 64 (2005) 321-324
117. Mahida Y.R., Wu K.C., and Jewell D.P. Characterization of antigen-presenting activity of intestinal mononuclear cells isolated from normal and inflammatory bowel disease colon and ileum. Immunology 65 (1988) 543-549
118. Rogler G., Hausmann M., Spottl T., Vogl D., Aschenbrenner E., Andus T., et al. T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa. Eur J Gastroenterol Hepatol 11 (1999) 1105-1111
119. Rugtveit J., Nilsen E.M., Bakka A., Carlsen H., Brandtzaeg P., and Scott H. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112 (1997) 1493-1505
120. + monocyte derived cells. Gut 37 (1995) 367-373
121. Rugtveit J., Bakka A., and Brandtzaeg P. Differential distribution of B7 1 (CD80) and B7. 2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 110 (1997) 104-113
122. Tokuyama H., Ueha S., Kurachi M., Matsushima K., Moriyasu F., Blumberg R.S., et al. The simultaneous blockade of chemokine receptors CCR2 CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Int Immunol 17 (2005) 1023-1034
123. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169 (2002) 10-14
124. Wyllie D.H., Kiss-Toth E., Visintin A., Smith S.C., Boussouf S., Segal D.M., et al. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol 165 (2000) 7125-7132
125. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285 (1999) 736-739
126. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NFκB by Toll-like receptor 3. Nature 413 (2001) 732-738
127. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
128. Jiang Q., Akashi S., Miyake K., and Petty H.R. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NFκB. J Immunol 165 (2000) 3541-3544
129. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001) 1099-1103
130. Means T.K., Hayashi F., Smith K.D., Aderem A., and Luster A.D. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 170 (2003) 5165-5175
131. Applequist S.E., Wallin R.P., and Ljunggren H.G. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 14 (2002) 1065-1074
132. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13 (2001) 933-940
133. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97 (2000) 13766-13771
134. Diebold S.S., Kaisho T., Hemmi H., and Akira S. Reis e Sousa C Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
135. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
136. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3 (2002) 196-200
137. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745